All News

On June 14, 2017, Western Connecticut Health Network (WCHN) announced its launch of a new study that will research the connection between pancreatic cancer and new-onset diabetes. This $2.7 million study will span 3 years and aims to discover a method to detect pancreatic cancer while it can still be cured.

A meta-analysis spearheaded by The International Testicular Cancer Consortium has identified new susceptibility loci in the human genome that can increase a person’s risk of developing inherited testicular germ cell tumors.

The collaboration between a digital behavioral health provider and an insurer comes as CMS admits challenges setting up the Medicare Diabetes Prevention Program.

Patients with chronic obstructive pulmonary disease (COPD) may dismiss medical advice if the benefit of the treatment is insignificant in comparison to the burden.

A drug previously used in an attempt to treat cancer, now has the potential to be repurposed to treat Duchenne muscular dystrophy.

The CMS Office of the Actuary released a report projecting the financial and coverage impacts of the American Health Care Act (AHCA) passed by the House of Representatives, finding that 13 million more people would be uninsured by 2026 but the federal government would reduce expenditures by $328 billion.

The American Medical Association (AMA) has announced its choice of Barbara McAneny, MD, to lead as president-elect, making her the first oncologist to take the reins of the nation’s largest physician organization.

The study's lead author said that complications from cardiovascular disease remain an unmet clinical challenge in type 2 diabetes.

A new report from CMS has shown that nearly 2 million people who selected an Affordable Care Act health plan on the exchanges did not pay their insurance premium to maintain health coverage just 2 months later.

The Supreme Court of the United States ruled in favor of Sandoz, on Monday, by allowing biosimilars to give notice of commercial marketing before or after FDA approval-meaning biosimilar products can be available sooner.

Patients with psoriasis often have lower success treatments with biologic agents in clinical practice than clinical trials, leading to higher doses and therefore higher annual treatment costs.

With the nation's largest commercial payer on board, the maker of the at-home DNA colon cancer screening test will put more focus on physician education and consumer awareness, with the hope of increasing screening rates for a test that patients find uncomfortable and inconvenient.

The theme of this year's American Society of Clinical Oncology (ASCO) Annual Meeting was Making a Difference in Cancer Care With You.

Prior data had indicated that sodium-glucose cotransporter 2 (SGLT2) inhibitors could be linked to diabetic ketoacidosis, a serious complication of diabetes.

This week, the top managed care stories included findings that some cancers are being diagnosed earlier after people gain coverage under the Affordable Care Act; a new poll gauged Americans' views on Medicaid; and JDRF launched a new campaign to meet the needs of people with type 1 diabetes.

With the sustainability and affordability of the US healthcare system in dire straits, now is the time for collaboration on new payment models, explained chief executive officers from a health plan and an insurer during a general session on the second day of America’s Health Insurance Plans’ Institute & Expo, held June 7-9 in Austin, Texas.

This series of blogs will illuminate aspects of racial equity in childbirth and highlight promising practices to ensure access to a safe, empowering, healthy, and positive birth for all people.

Coverage of peer-reviewed research from AJMC® in the healthcare and mainstream press.

The United States is only slightly halfway through its healthcare transformation, claimed Mike Leavitt, founder and partner of Leavitt Partners and the former governor of Utah, during a general session on the first day of America’s Health Insurance Plans Institute & Expo, held June 7-9, in Austin, Texas.

The investigational oral therapy, upadacitinib, is a potential competitor for Pfizer's JAK inhibitor, which treats patients who are not responding adequately to DMARDs.

A new study analyzing breast cancer data in the SEER database has concluded that small tumors detected following a mammography might be small because they are slow-growing, and not necessarily because they were detected early.

Patients with comorbid depression and chronic obstructive pulmonary disease (COPD) have low rates of adherence to their COPD management medications, putting them at increased risk of emergency department visits and hospitalizations.

A new study finds that the incidence of cancer in high-income counties has spiked higher than in low-income counties, but the wealthier areas saw their cancer mortality rates decrease more, which could indicate that overdiagnosis is occurring among well-off populations.

Being isolated due to being overweight can have long-term health consequences, and the study's lead author said reducing stigma should be part of anti-bullying efforts.

During a general session at America’s Health Insurance Plans’ Institute & Expo, held June 7-9 in Austin, Texas, Eric Topol, MD, explained the buzz behind precision medicine and why it is needed to combat the harms of imprecision in medicine.